Call us: +202 22 905 906
E-Mail: mail@alpha-pharmaceuticals.com
You are here
National Institutes of Health (NIH)
NIH, NIAID, scientists, human, cerebral organoid, test, drug, Creutzfeldt-Jakob disease.
Protein AEG12 strongly inhibits the family of viruses that cause yellow fever, dengue, West Nile, and Zika.
Researchers hope the new approach will be used as a framework for publishing studies on polygenic risk scores.
.
By eliminating extraneous light, the scientists improved resolution by 33%.
“Phage” therapies offer potential strategy to combat antibacterial resistance.
Novel research in mice sheds light on hormone regulation needed in late pregnancy, opens door for therapy.
Authors explain seven opportunities to accelerate tailored medicine efforts and create a more equitable health landscape in the future.
Results are from a large clinical trial in the United States and South America.
Such programs could lead to improvements in body mass index later in life.
Late Monday, the Data and Safety Monitoring Board (DSMB) notified NIAID, BARDA, and AstraZeneca that it was concerned by information released by AstraZeneca on initial data from its COVID-19 vaccine clinical trial.